Drug Development

Articles

Recipharm is investing more than EUR1.2 million to enhance its small-scale GMP API development and manufacturing capabilities in Paderno Dugnano, Italy.

Recipharm Adds New Lab to Italian API Facility

Oxford Genetics has secured a GBP1 million capital from investment group Mercia Technologies to support its growth strategy in delivering new services for cancer-fighting gene-therapy technologies.

Oxford Genetics Secures GBP1 Million Investment for Gene Therapy Technologies

Ashland opened a new pharmaceutical excipient manufacturing facility in Nanjing, China.

Ashland Opens Manufacturing Facility in China

Horizon announces new bioproduction outlicense deal with an unnamed partner for a minimum value of £500,000.

Horizon Discovery Signs Subscription-Based Licensing Agreement for Biomanufacturing Cell Lines

Capsugel’s intrinsically enteric capsule technology provides enteric protection and delayed release without a functional coating. Merck’s Parteck SRP 80 sustained-release excipient is well suited for direct compression.

Capsugel and Merck KGaA Named Winners of the Formulation and Excipients Category of the CPhI Pharma Awards

Pharmaceutical Technology Europe will be exhibiting at CPhI Worldwide at Stand 3G98.

Come Visit the PharmTech Europe Booth

he guidance addresses the good manufacturing practice for managing quality in APIs.

FDA Releases Q7 GMP for API Guidance

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Excipients play a crucial role in the manufacturing of solid-dosage forms and the performance of the finished drug product.

Excipients for Formulation Success

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Researchers develop catalysts that mediate complex transformations under conditions appropriate for commercial manufacture.

The Search for Practical and Economical Catalysts

The current approach of classifying process parameters and quality attributes as critical or non-critical is too simplistic to adequately reflect current science and risk-based approaches to product quality.

APIs and Excipients